PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.56%
Revenue growth under 50% of AVGO's 4.46%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-0.22%
Negative gross profit growth while AVGO is at 4.45%. Joel Greenblatt would examine cost competitiveness or demand decline.
-0.70%
Negative EBIT growth while AVGO is at 10.11%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1.65%
Negative operating income growth while AVGO is at 10.11%. Joel Greenblatt would press for urgent turnaround measures.
0.17%
Net income growth under 50% of AVGO's 18.69%. Michael Burry would suspect the firm is falling well behind a key competitor.
1.21%
EPS growth under 50% of AVGO's 15.87%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
0.82%
Diluted EPS growth under 50% of AVGO's 16.39%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.76%
Share reduction while AVGO is at 2.56%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.75%
Reduced diluted shares while AVGO is at 1.42%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.09%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
56.45%
OCF growth above 1.5x AVGO's 4.27%. David Dodd would confirm a clear edge in underlying cash generation.
68.74%
FCF growth above 1.5x AVGO's 3.61%. David Dodd would verify if the firm’s strategic investments yield superior returns.
91.35%
10Y revenue/share CAGR under 50% of AVGO's 715.70%. Michael Burry would suspect a lasting competitive disadvantage.
37.79%
5Y revenue/share CAGR under 50% of AVGO's 83.99%. Michael Burry would suspect a significant competitive gap or product weakness.
42.33%
3Y revenue/share CAGR similar to AVGO's 45.60%. Walter Schloss would assume both companies experience comparable short-term cycles.
184.81%
10Y OCF/share CAGR under 50% of AVGO's 1918.51%. Michael Burry would worry about a persistent underperformance in cash creation.
73.82%
Below 50% of AVGO's 159.18%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
42.20%
3Y OCF/share CAGR at 50-75% of AVGO's 73.51%. Martin Whitman would suspect weaker recent execution or product competitiveness.
262.30%
Below 50% of AVGO's 1138.11%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
93.27%
Below 50% of AVGO's 520.03%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
64.93%
Below 50% of AVGO's 307.89%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
57.46%
Below 50% of AVGO's 433.32%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
42.87%
5Y equity/share CAGR above 1.5x AVGO's 2.41%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
65.35%
Positive short-term equity growth while AVGO is negative. John Neff sees a strong advantage in near-term net worth buildup.
570.52%
Below 50% of AVGO's 2640.14%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
129.76%
Below 50% of AVGO's 356.43%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
49.28%
3Y dividend/share CAGR at 75-90% of AVGO's 55.82%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
-6.85%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
9.32%
Inventory growth well above AVGO's 10.19%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.40%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.73%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
9.57%
Debt growth far above AVGO's 0.07%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
4.11%
We increase R&D while AVGO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
2.13%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.